K-ras oncogene activation in lung adenocarcinomas from former smokers. Evidence that K-ras mutations are an early and irreversible event in the development of adenocarcinoma of the lung

作者: William H. Westra , Robbert J. C. Slebos , G. Johan A. Offerhaus , Steven N. Goodman , Siegina G. Evers

DOI: 10.1002/1097-0142(19930715)72:2<432::AID-CNCR2820720219>3.0.CO;2-#

关键词:

摘要: Background. Point mutations in codon 12 of the K-ras protooncogene occur more frequently lung adenocarcinomas from smokers (30%) than they do nonsmokers (7%), suggesting that smoking is an important factor induction these mutations. The lack well defined “early” premalignant or situ glandular neoplasms lung, however, has not permitted direct evaluation chronology ras activation development adenocarcinomas. To circumvent need to evaluate precursor lesions, we examined former for point K-ras. Methods. Mutations were detected using polymerase chain reaction amplification and mutation-specific oligonucleotide probes. types frequencies found obtained 57 compared those 27 patients who never smoked current smokers. Results. overall prevalence (32%) was different seen (30%, P = 0.83), greater (7%, 0.015). This pattern independent duration abstinence smoking. Furthermore, predominant type mutation tumors a guanine-to-thymine transversion, specific induced by benzo(a)pyrene, one chemical carcinogens tobacco smoke. Conclusions. These findings support previous suggest oncogene may be target mutagenic activity smoke, DNA alterations at this site can early irreversibly during lung.

参考文章(36)
C. Everett Koop, Smoking and cancer. Hospital Practice. ,vol. 19, pp. 107- 132 ,(1984) , 10.1080/21548331.1984.11702845
Slebos Rj, Rodenhuis S, The Ras Gene Family in Human Non-Small-Cell Lung Cancer Journal of The National Cancer Institute Monographs. pp. 23- ,(1992)
Mitsudomi T, Minna Jd, Gazdar Af, Mulshine Jl, Viallet J, Linnoila Ri, Mutations of ras genes distinguish a subset of non-small-cell lung cancer cell lines from small-cell lung cancer cell lines Oncogene. ,vol. 6, pp. 1353- 1362 ,(1991)
Nicholas R. Lemoine, Sunjay Jain, Christine M. Hughes, Susan L. Staddon, Bernard Maillet, Peter A. Hall, Günter Klöppel, Ki-ras oncogene activation in preinvasive pancreatic cancer Gastroenterology. ,vol. 102, pp. 230- 236 ,(1992) , 10.1016/0016-5085(92)91805-E
R. H. Hruban, T. W. Kensler, D. H.J. Van Weering, J. L. Cameron, S. N. Goodman, A. D.M. Van Mansfeld, K. K. Bose, David C. Allison, G. J.A. Offerhaus, J. L. Bos, K-ras oncogene activation in adenocarcinoma of the human pancreas. A study of 82 carcinomas using a combination of mutant-enriched polymerase chain reaction analysis and allele-specific oligonucleotide hybridization. American Journal of Pathology. ,vol. 143, pp. 545- 554 ,(1993)
Kary B. Mullis, Fred A. Faloona, Specific synthesis of DNA in vitro via a polymerase-catalyzed chain reaction. Methods in Enzymology. ,vol. 155, pp. 335- 350 ,(1987) , 10.1016/0076-6879(87)55023-6
Bernard S. Strauss, The origin of point mutations in human tumor cells. Cancer Research. ,vol. 52, pp. 249- 253 ,(1992)
S. Rodenhuis, S. S. Wagenaar, W. J. Mooi, A. J. M. Boot, R. J. C. Slebos, P. C. Van Bodegom, S. G. Evers, J. L. Bos, Incidence and Possible Clinical Significance of K- ras Oncogene Activation in Adenocarcinoma of the Human Lung Cancer Research. ,vol. 48, pp. 5738- 5741 ,(1988)
Takehiko Sasazuki, Hideki Yokoyama, Teruyoshi Ishida, Takashi Inoue, Keizo Sugimachi, Kenji Sugio, ras gene mutations as a prognostic marker in adenocarcinoma of the human lung without lymph node metastasis. Cancer Research. ,vol. 52, pp. 2903- 2906 ,(1992)
Sjoerd Rodenhuis, Robert J. C. Slebos, Clinical significance of ras oncogene activation in human lung cancer. Cancer Research. ,vol. 52, pp. 2665- 2669 ,(1992)